TTrialPathMatch Me to Trials
← Back to trials
RecruitingPregnancy, High RiskType 1 DiabetesType 2 Diabetes

Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)

Eligible age

18+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

PRISM is a single center non-inferiority randomized controlled trial of permissive intrapartum glucose management (intervention) versus strict intrapartum glucose management (standard of care) among pregnant individuals with pregestational diabetes using hybrid closed loop therapy (HCL) who are admitted for labor management. Participants will be randomized in a 1:1 fashion to one of two intrapartum glycemic control options: permissive (70-140 mg/dL) or strict (70-110 mg/dL). The primary aim of this trial it to demonstrate that permissive intrapartum glucose management is not associated with an increased risk of neonatal dysglycemia compared with strict intrapartum glucose management.

Sponsor: Ohio State University

You may qualify if…

  • ✓ Pregnant individuals
  • ✓ ≥ 18 years old
  • ✓ Type 1 and Type 2 diabetes
  • ✓ Intention for vaginal delivery and admitted to Labor and Delivery
  • ✓ Singleton, non-anomalous fetus
  • ✓ Gestational age greater than or equal to 35 weeks gestation.
  • ✓ Cervical dilation is less than 6 cm.
  • ✓ Delivering at the study institution

You may not qualify if…

  • ✕ Scheduled cesarean delivery
  • ✕ Cervical dilation ≥ 6 cm on presentation to L\&D
  • ✕ Receipt of antenatal corticosteroids within 7 days of randomization
  • ✕ Fetal demise
  • ✕ Major fetal anomaly (attached)
  • ✕ Multiple gestation
  • ✕ Non-English speaking

Where it's recruiting

Ohio

Columbus

Source: ClinicalTrials.gov · NCT07293715 · last updated 2026-11-09

Permissive Versus Strict Intrapartum Glucose Management in Type 1 and · TrialPath